Viewing Study NCT04691661


Ignite Creation Date: 2025-12-24 @ 12:13 PM
Ignite Modification Date: 2026-01-01 @ 10:44 PM
Study NCT ID: NCT04691661
Status: RECRUITING
Last Update Posted: 2024-07-16
First Post: 2020-12-16
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety, Tolerability, Pharmacokinetics and Efficacy Study of Radotinib in Parkinson's Disease
Sponsor: Il-Yang Pharm. Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module